GSK to Buy US-based IDRx for Up to $1.15 Billion to Boost Gastrointestinal Cancer Pipeline

Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,443.50 GBX | -1.50% |
|
+3.22% | +7.20% |
Feb. 10 | GSK : Deutsche Bank gives a Neutral rating | ZD |
Feb. 07 | GSK : Bernstein gives a Buy rating | ZD |